License: Creative Commons Attribution 4.0 PDF - Published Version (940kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-569073
- DOI to cite this document:
- 10.5283/epub.56907
Abstract
Background Although multiparametric magnetic resonance imaging (mpMRI) is recommended for primary risk stratification and follow-up in Active Surveillance (AS), it is not part of common AS inclusion criteria. The objective was to compare AS eligibility by systematic biopsy (SB) and combined MRI-targeted (MRI-TB) and SB within real-world data using current AS guidelines. Methods A ...
Owner only: item control page